L-298-2019
Agreement ID
L-298-2019
Lead IC
NIAID
Exclusivity
Exclusive
External Party
GlaxoSmithKline Intellectual Property Limited (GSK)
Fiscal Year
2020
Territory
Worldwide
Execution Date
Effective Date
Export Date